openPR Logo
Press release

Vaccine Market to Witness Huge Growth by 2024| Key Players are GlaxoSmithKline plc, Merck & Co., Inc., Sanofi S.A. (Sanofi Pasteur) and Pfizer Inc.

01-11-2021 03:02 PM CET | Health & Medicine

Press release from: MarketReportsOnline

Global Vaccine Market Growth Analysis and Forecast to 2024

Global Vaccine Market Growth Analysis and Forecast to 2024

MarketReportsOnline.com the exclusive leading provider of market research reports published research report on “Global Vaccine Market: Size & Forecasts with Impact Analysis of COVID-19 (2020-2024)”.

The report titled “Global Vaccine Market: Size & Forecasts with Impact Analysis of COVID-19 (2020-2024)” provides an in depth analysis of the global vaccine market by value, by disease, by type, by patient type, by region, etc.

Get Free Sample PDF Copy at https://www.marketreportsonline.com/contacts/requestsample.php?name=801592.

The report provides a regional analysis of the vaccine market, including the following regions: North America (the US & Rest of North America), Europe, Asia Pacific (China, Japan, India & Rest of Asia Pacific), Latin America and Middle East and Africa. The report also provides a detailed analysis of the COVID-19 impact on the vaccine market.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global vaccine market has also been forecasted for the period 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The global vaccine market is highly dominated with few major market players operating worldwide. The manufacturers of vaccinesproduce different types of vaccines for different diseases and for the patients of different age group. Further, key players of the vaccine market are GlaxoSmithKline plc, Merck & Co., Inc., Sanofi S.A. (Sanofi Pasteur), and Pfizer Inc. are also profiled with their financial information and respective business strategies.

Country Coverage:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Company Coverage Analysis:
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Sanofi S.A. (Sanofi Pasteur)
• Pfizer Inc.

Purchase a copy of this exclusive report on Vaccine Market: Size & Forecasts with Impact Analysis of COVID-19 available at https://www.marketreportsonline.com/contacts/purchase.php?name=801592.

Vaccines are substances that inject a weakened form of disease into a person’s body, to stimulate the production of antibodies and to provide immunity against the infectious diseases. While drugs are administered to patients to treat medical problems, vaccines are administered to healthy children or adults to prevent infectious diseases. Vaccines can be injected through a needle; taken by mouth; and inhaled through the nose. Vaccine is considered to be very important, as it protects children from serious complications of preventable diseases. Vaccine is also safe and effective, as it is carefully reviewed by the scientists, doctors and researchers in different phases and trials. Vaccine is also proved beneficial in protecting future generations, because it reduced or may have eliminated the impact of many diseases that killed people just a few generations ago.

There are four main types of vaccines: Live-attenuated vaccines, Inactivated Vaccines, Recombinant/Conjugate/Subunit Vaccines, and Toxoid Vaccines. Vaccines have a long history with continuously evolving premium and new generation vaccines. The vaccine market can be segmented on the basis of disease, type, route of administration, patient type, and end-users.

The global vaccine market has increased at a significant CAGR during the years 2015-2019 and projections are made that the market would rise in the next four years i.e. 2020-2024 tremendously. The vaccine market is expected to increase due to increasing prevalence of infectious diseases, rising focus on immunization, growing population, escalating healthcare spending, surge in the use of adjuvants, rising initiatives by the government and non-government organizations, etc. Yet the market faces some challenges such as inadequate access to vaccines, stringent regulations, etc.

Few Points from List of Tables & Figures (https://www.marketreportsonline.com/801592-toc.html):

List of Tables

Table 1: Global Vaccine Market Players by Major Merger & Acquisition (M&A) Deals
Table 2: Global Vaccine Market Players by Vaccine Pipelines
Table 3 : Global Vaccine Market Players by Vaccines in the Pipelines for COVID-19

List of Figures
Figure 1: Importance of Vaccine
Figure 2: History of Vaccine
Figure 3: Types of Vaccines
Figure 4: Vaccine Segmentation by Disease
Figure 5: Vaccine Segmentation by Type and Route of Administration
Figure 6: Vaccine Segmentation by Patient Type and End-users
Figure 7: Global Vaccine Market by Value; 2015-2019 (US$ Billion)
Figure 8: Global Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 9: Global Vaccine Market by Disease; 2019 (Percentage, %)
Figure 10: Global Vaccine Market by Type; 2019 (Percentage, %)
Figure 11: Global Vaccine Market by Patient Type; 2019 (Percentage, %)
Figure 12: Global Vaccine Market by Region; 2019 (Percentage, %)
Figure 13: Global Streptococcus Pneumonia Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 14: Global Streptococcus Pneumonia Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 15: Global DTP Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 16: Global DTP Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 17: Global Influenza Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 18: Global Influenza Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 19: Global Cancer Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 20: Global Cancer Vaccine Market by Value; 2020-2024 (US$ Billion)

Inquire more before buying this report at https://www.marketreportsonline.com/contacts/inquirebeforebuying.php?name=801592.

Connect us @ sales@marketreportsonline.com OR Call Us @ +1 888 391 5441

MarketReportsOnline.com is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage. Category focused research, country reports, company profiles, regional and global industry profiles and guides to premium reports offering extensive coverage

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaccine Market to Witness Huge Growth by 2024| Key Players are GlaxoSmithKline plc, Merck & Co., Inc., Sanofi S.A. (Sanofi Pasteur) and Pfizer Inc. here

News-ID: 2223329 • Views:

More Releases from MarketReportsOnline

US Lettuce & Chicory Market Key Players, Exports & Imports, Size, Share, Demands …
The US lettuce and chicory market is forecasted to reach US$5.09 billion in 2026, experiencing growth at a CAGR of 2.62% during the period spanning from 2022 to 2026. Growth in the lettuce and chicory market is supported by factors such as rising population, rising middle class spending, shift towards veganism/ vegetarianism, increasing awareness regarding the health benefit of chicory and rising social media influence. However, the market growth is
Global Breast Biopsy Market - Hologic, Danaher Corporation, Becton, Dickinson & …
The global breast biopsy market is forecasted to reach US$1.75 billion in 2025, experiencing growth at a CAGR of 8.56% for the period spanning 2022-202. Growth in the global breast biopsy market was supported by factors such as increasing prevalence of breast cancer and rising female population aged 65 or above. Growing adoption of liquid biopsy is likely to have a positive impact on the global breast biopsy market. However,
Global Contract Development & Manufacturing Organization Market - Catalent, Inc. …
The global Contract Development & Manufacturing Organization (CDMO) market is estimated to reach US$246.6 billion in 2026, growing at a CAGR of 9.31%, for the period spanning 2022-2026. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments and strategic collaborations and growing demand for pharmaceutical products are expected to drive the market.
Korean Gaming Market (Mobile, PC and Console) - Netmarble, Pearl Abyss, NCSoft, …
The Korean gaming market is anticipated to reach US$20.98 billion in 2026, growing at a CAGR of 6.21% during the period spanning 2022-2026. After the U.S., China, and Japan, it is the fourth largest market, accounting for more than 6% of the worldwide gaming industry in 2021. The growth in the market has been driven by factors like rising smartphone penetration, rapid urbanization, rising gaming subscribers' penetration rate, expansion of MMORPGs,

All 5 Releases


More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the